2 results about "Estrogen receptor activity" patented technology

Described herein are endoxifen compositions comprising novel compounds and methods of use thereof. Methods of synthesis for the compositions are described herein. The endoxifen compositions described herein may exhibit aromatase inhibition activity or estrogen receptor activity. The endoxifen compositions described herein may be useful in the treatment of a condition in a subject, such as cancer.

The present disclosure provides 1) enantiomerically pure compounds SRR G-1 or its derivatives, including specific crystalline forms, salts and co-crystals that modulate G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising enantiomerically pure SRR G-1 or its derivatives and 3) methods of treating or preventing disease states and conditions mediated by these receptors in humans and animals as well as methods for cosmetic conditions and related methods.